| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |